Guidelines for Authors
This is an international Open Access journal devoted to the promotion of pharmaceutical sciences and related disciplines (including biotechnology, cell and molecular biology, drug utilization including adverse drug events, medical and other life sciences, and related engineering fields). It seeks particularly (but not exclusively) to encourage pharmaceutical and allied research of tropical relevance and to foster multidisciplinary research and collaboration among scientists, the pharmaceutical industry and the healthcare professionals. It also provides an international forum for the communication and evaluation of data, methods and findings in pharmaceutical sciences and related disciplines. Although primarily devoted to original research papers, the journal welcomes reviews on current topics of special interest and relevance.
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) are published without delay.
The maximum length of manuscripts should be 6000 words (24 double-spaced typewritten pages) for review, 4000 words (18 pages) for research articles, 1,500 (6 pages) for technical notes, commentaries and short communications.
The following types of manuscripts will not be considered for publication:
"I confirm that this manuscript being submitted has not been previously published, and is not under consideration for publication elsewhere."
This journal subscribes to \'Standards for Authors available at http://publicationethics.org/international-standards-editors-and-authors or http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021155
For editors and reviewers to accurately evaluate the work presented in your manuscript, you need to ensure the English language is of sufficient quality to be understood. It is strongly advices that authors should thoroughly read through the document on how to present a manuscript available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626472/. If you need help with writing in English you should consider reading the article available under English language tutorial which covers the common mistakes when writing in English. Authors who wish to have their manuscripts reviewed by a company that specializes in medical editing and proofreading prior to journal submission, may send their documents to Medscience Editors (http://www.medscienceeditors.com) or BioScience Writers (www.biosciencewriters.com) for fast personalized editing services. Please note that the use of a language editing service is not a requirement for publication in this journal and is not a guarantee that the article will be selected for peer review or accepted for publication.
Authors using experimental animals and human subjects in their investigation must seek approval from the appropriate Ethical Committee in accordance with "Principles of Laboratory Animal Care" (NIH publication no. 85-23, revised 1985) and/or the declaration of Helsinki promulgated in 1964 as amended in 1996. The method section must include a statement to prove that the investigation was approved and that informed consent was obtained.
The language of the journal is English. Each manuscript should be typed double-spaced on A4 (8.5" x 11") paper size with 1 inch margins. It should be arranged in the following order:
Title PageThe title page should:
AbstractThe Abstract should not exceed 300 words. Please minimize the use of abbreviations and do not cite references in the abstract. Reports of randomized controlled trials should follow the CONSORT extension for abstracts. The abstract must include the following separate sections:
Introduction: the context (1-2 sentences) and purpose of the study
Methods: how the study was performed, the outcomes measured and statistical tests used
Results: what was found (no discussion)
Conclusion: what is concluded, potential implications and possible policy statement
Trial registration: If your article reports the results of a health care intervention on human participants, it must be registered in an appropriate registry and the registration number and date of registration should be in stated in this section. If it was not registered prospectively (before enrollment of the first participant), you should include the words \'retrospectively registered\'. See our editorial policies for more information on trial registration
Keywords: Three to ten keywords representing the main content of the article.
The background section should explain the background to the study, a summary of the existing evidence, highlights of the gap in existing evidence, and why this study was necessary or its contribution to the field. The purpose should be provided in the last paragraph.
MethodsThe methods section should include:
This should include the findings of the study including, if appropriate, results of statistical analysis which must be included either in the text or as tables and figures. The results should not be discussed here.
DiscussionIn the first paragraph, the key findings should be summarized. In subsequent paragraphs, those key findings should be discussed in context of existing literature evidence. This section should also discuss the implications (clinical, humanistic and or economic) of the findings and highlight limitations of the study.
ConclusionsThis should state clearly the main conclusions and provide an explanation of the importance and relevance of the study reported.
List of abbreviations
If abbreviations are used in the text, they should be defined in the text at first use, and a list of the abbreviations should be provided.
DeclarationsAll manuscripts must contain the following sections under this heading:
The details on the information to be included in these sections are below.
If any of the sections are not relevant to your manuscript, please include the heading and write \'Not applicable\' for that section.
Ethics approval and consent to participateManuscripts reporting studies involving human participants, human data or human tissue must:
Studies involving animals must include a statement on ethics approval and for experimental studies involving client-owned animals, authors must also include a statement on informed consent from the client or owner. See our editorial policies for more information.
If your manuscript does not report on or involve the use of any animal or human data or tissue, please state “Not applicable” in this section.
Consent for publication If your manuscript contains any individual person’s data in any form (including any individual details, images or videos), consent for publication must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent for publication.
You can use your institutional consent form or the one available at consent form as a sample if you prefer. You should not send the form to us on submission, but we may request to see a copy at any stage (including after publication).
See our editorial policies for more information on consent for publication.
If your manuscript does not contain data from any individual person, please state “Not applicable” in this section.
Availability of data and materials
All manuscripts must include an ‘Availability of data and materials’ statement. Data availability statements should include information on where data supporting the results reported in the article can be found including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. By data we mean the minimal dataset that would be necessary to interpret, replicate and build upon the findings reported in the article. We recognise it is not always possible to share research data publicly, for instance when individual privacy could be compromised, and in such instances data availability should still be stated in the manuscript along with any conditions for access.
Data availability statements can take one of the following forms (or a combination of more than one if required for multiple datasets):
Murri R, Fantoni M, Borgo CD, Visona R, Barracco A, Zambelli A, Testa L, Orchi N, Tozzi V, Bosco O, Wu AW. Determinants of health-related quality of life in HIV-infected patients. AIDS Care 2003;15:581-590. doi: https://doi.org/10.23456/t814342
Hanley C. Metaphysics and innateness: a psychoanalytic perspective. Int J Psychoanal 1988;69(Pt 3):89-99. doi: https://doi.org/10.23456/t814332
Danoek K. Skiing in and through the history of medicine. Nord Medicinhist Arsb 1982:86-100 doi: https://doi.org/10.23456/t814345
Baumeister AA. Origins and control of stereotyped movements. Monogr Am Assoc Ment Defic 1978;(3):353-384. doi: https://doi.org/10.23456/t8143889
Edwards L, Meyskens F, Levine N. Effect of oral isotretinoin on dysplastic nevi. J Am Acad Dermatol 1989 20(2 Pt 1):257-260. doi: https://doi.org/10.23456/t8143428989
Matthews DE, Farewell VT. Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger, 1996.
Ohlsen, Merle M.; Horne, Arthur M.; Lowe, Charles F. Group counseling. New York: Holt, Rinehart, and Winston; 1988. p. 416.
Diener, Hans-Christoph; Wilkinson, Marcia, editors. Drug-induced headache. New York: Springer-Verlag; 1988 p. 173.
Anderson, Robert J.; Schrier, Robert W. Acute renal failure. In: Braunswald, Eugene; Isselbacher, Kurt J.; Petersdorf, Robert G., et al., editors. Harrison\'s principles of internal medicine. 11th ed. New York: McGraw-Hill; 1987. pp. 1149-1155.
Hypertension, Dialysis & Clinical Nephrology [homepage on the Internet]. Hinsdale (IL): Medtext, Inc.; c1995-2001 [cited 2001 Mar 8]. Available from: http://www.medtext. com/hdcn.htm [cited 12 Jun 2020]
Pennington J. HIV/AIDS in Nigeria, 2007. Available from: http://www.avert.org/aids-nigeria.htm [cited 12 Jun 2020]
Medlineplus [Internet]. Bethesda (MD): National Library of Medicine (US). Available from: http://medlineplus.gov [updated 2000 Apr 7; cited 18 Apr 2000].
Bertram, Kenneth. The role of natural killer activity in resistance to herpesvirus-induced disease. [Rochester]: University of Minnesota; 1981 Dec. p.138 [dissertation]
Each Table should be inserted at an appropriate position in the text closed to where it was first cited and numbered with arabic numerals using single space to separate the Table and the number (eg, Table 1, Table 2, etc). Where there is more than one Table, each Table should be cited independently (do not refer to more than one Table) in text. The maximum number of Tables allowed in a manuscript is nine (9).
Each table should be typed using a table format (ie, each variable must be typed into a separate cell in the table) with only horizontal lines above and below the table column headers and at the bottom of the table (using 1 pt for the top and bottom lines and 0.5 point for any middle line). No vertical lines should be included in any table. Each table MUST not exceed 6.5 x 7 inches (16.5 x 17.8 cm, width x height) and MUST be inserted at the appropriate position in the text just below where it was referred to the first time. The title should be typed at the top of the table in the sentence case format, i.e., only the first name should be in capital letters; names should also be in capital letters, as appropriate. Any footnote should be typed at the top and bottom of the table in italic.
All Figures, Schemes and Illustrations should be be clear and sharp, and labelled as Figures and numbered with arabic numerals using signle space to separate the Figure and the number (eg, Figure 1, Figure 2, etc) and refered to independently (do not refer to more than one figure at the same time) in text. The maximum number of Figures allowed in a paper is nine (9).
Each figure should be professionally drawn electronically and inserted in the appropriate position where it was first cited within the text. Symbols, lettering, and numbering MUST NOT be in bold print and should be clear and large enough to remain legible (be at least 9 points in size) after the figure has been reduced to 1/2 of the original size. The legend and any footnote for each figure should be typed below the figure.
Photographs/Figures may be produced in any color. If photographs of patients are used, either the subjects are not identifiable or their pictures must be accompanied by a written permission to use the images.
Authors should target their Figures to width of 85 mm for half page column. Where this is not possible, width of 170 mm for full page should be considered. Image resolution should not be less than approximately 300 dpi (dots per inch) at the final size.
Labels of Figures MUST be in text form and MUST not form part of the image.
There is no charge for submitting a manuscript. But once a manuscript is accepted for publication, the author(s) will be required to pay a publication charge of US$100.00 before the accepted paper is published. Authors may opt for fast-track (accelerated) review and publication which attracts a special publication charge of US$200.00 if the manuscript is accepted for publication. Manuscripts that fall under fast-track option would be published, if accepted for publication, within 1 - 2 months from the time they are sent for review while those on normal track may take much longer period.
Submission of a manuscript to this journal is an indication that the manuscript has not been published previously and is not under consideration for publication elsewhere. All authors named in each manuscript would be required to sign a copyright form so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Unless indicated otherwise, galley proofs are sent to the address given for correspondence. It is the responsibility of the corresponding author to ensure that the galley proofs are returned without delay.
MANUSCRIPT SUBMISSION CHECK-LIST
Please carefully go through the following check list. Non-compliance with TJPR manuscript formatting requirements will result in the manuscript being returned to the corresponding author for reformatting or rejection.